Invest A/S Lundbeckfond

IOBT

Invest A/S Lundbeckfond serves as 10% Owner at IO Biotech, Inc. (IOBT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$32.50M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$32.50M

Companies Traded

LXEO, IOBT

Active Period

Nov 2021 – Nov 2023

2 total trades

Most Recent

Buy LXEO

Nov 9, 2023 · $2.50M

Invest A/S Lundbeckfond's Insider Trading at IO Biotech, Inc. (IOBT)

Buys

1 · $30.00M

Sells

0 · $0.00

Total Shares Bought

2,142,857

Total Shares Sold

IOBT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 12, 2021	Buy	2,142,857	$14.00	$30.00M	6,049,452

Invest A/S Lundbeckfond's Insider Trading at Lexeo Therapeutics, Inc. Common Stock (LXEO)

Buys

1 · $2.50M

Sells

0 · $0.00

Total Shares Bought

227,272

Total Shares Sold

LXEO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 9, 2023	Buy	227,272	$11.00	$2.50M	1,835,959

Related Insiders

Narinder Pal Bhalla

officer: Chief Medical Officer

LXEOSell · Jul 1, 2026

Jose Manuel Otero

officer: Chief Operating Officer

LXEOSell · Jul 1, 2026

Louis Edward Tamayo

officer: Chief Financial Officer

LXEOSell · Jul 1, 2026

Richard Nolan Townsend

director, officer: Chief Executive Officer

LXEOSell · Jul 1, 2026

Explore More Insider Trading Data

IOBT Insider Trading Activity

View all insider trades at IO Biotech, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity